Analysts Set Henry Schein, Inc. (NASDAQ:HSIC) Target Price at $81.09

Shares of Henry Schein, Inc. (NASDAQ:HSIC) have earned an average rating of “Hold” from the eleven ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, five have given a hold recommendation and five have given a buy recommendation to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $81.73.

A number of equities analysts have weighed in on HSIC shares. Barrington Research lifted their price objective on Henry Schein from $90.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday. JPMorgan Chase & Co. boosted their price objective on Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a research report on Wednesday, March 6th. UBS Group dropped their price target on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday. Evercore ISI upped their price target on shares of Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research report on Wednesday, February 28th. Finally, Leerink Partnrs restated a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th.

Henry Schein Stock Performance

Shares of HSIC opened at $72.76 on Monday. The stock has a 50-day moving average of $73.01 and a two-hundred day moving average of $72.34. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.00 and a current ratio of 1.67. The stock has a market cap of $9.35 billion, a P/E ratio of 23.10, a P/E/G ratio of 1.68 and a beta of 0.87. Henry Schein has a one year low of $60.01 and a one year high of $82.63.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.09. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.21 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. Henry Schein’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.21 EPS. As a group, research analysts predict that Henry Schein will post 5.07 EPS for the current year.

Insider Activity

In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the firm’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares in the company, valued at $5,430,462.24. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now directly owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Institutional Investors Weigh In On Henry Schein

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Sei Investments Co. raised its holdings in Henry Schein by 5.9% during the first quarter. Sei Investments Co. now owns 389,789 shares of the company’s stock worth $29,437,000 after purchasing an additional 21,740 shares in the last quarter. Foyston Gordon & Payne Inc boosted its position in shares of Henry Schein by 99.5% in the 1st quarter. Foyston Gordon & Payne Inc now owns 144,102 shares of the company’s stock valued at $10,883,000 after purchasing an additional 71,870 shares during the period. Forsta AP Fonden grew its stake in Henry Schein by 8.9% during the 1st quarter. Forsta AP Fonden now owns 24,500 shares of the company’s stock worth $1,850,000 after buying an additional 2,000 shares during the last quarter. Illinois Municipal Retirement Fund lifted its stake in Henry Schein by 0.6% in the first quarter. Illinois Municipal Retirement Fund now owns 95,899 shares of the company’s stock valued at $7,242,000 after buying an additional 575 shares during the last quarter. Finally, Nuance Investments LLC boosted its holdings in shares of Henry Schein by 28.5% in the first quarter. Nuance Investments LLC now owns 1,755,190 shares of the company’s stock valued at $132,552,000 after acquiring an additional 388,843 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.